| Authors: |
Agnew E; Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK. Electronic address: emily.agnew@ukhsa.gov.uk., Davies KA; COMBACTE-CDI European Coordinator Laboratory, Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridioides difficile, UK., Viprey VF; COMBACTE-CDI European Coordinator Laboratory, Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Evans S; Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK., Davis GL; COMBACTE-CDI European Coordinator Laboratory, Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Hope R; Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK., Wilcox MH; COMBACTE-CDI European Coordinator Laboratory, Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridioides difficile, UK., Wingen-Heimann SM; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; FOM University of Applied Sciences, Cologne, Germany., Robotham JV; Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK. |
